UniProt ID | PLAK_HUMAN | |
---|---|---|
UniProt AC | P14923 | |
Protein Name | Junction plakoglobin | |
Gene Name | JUP | |
Organism | Homo sapiens (Human). | |
Sequence Length | 745 | |
Subcellular Localization |
Cell junction, adherens junction . Cell junction, desmosome . Cytoplasm, cytoskeleton . Membrane Peripheral membrane protein . Cytoplasmic in a soluble and membrane-associated form. |
|
Protein Description | Common junctional plaque protein. The membrane-associated plaques are architectural elements in an important strategic position to influence the arrangement and function of both the cytoskeleton and the cells within the tissue. The presence of plakoglobin in both the desmosomes and in the intermediate junctions suggests that it plays a central role in the structure and function of submembranous plaques. Acts as a substrate for VE-PTP and is required by it to stimulate VE-cadherin function in endothelial cells. Can replace beta-catenin in E-cadherin/catenin adhesion complexes which are proposed to couple cadherins to the actin cytoskeleton (By similarity).. | |
Protein Sequence | MEVMNLMEQPIKVTEWQQTYTYDSGIHSGANTCVPSVSSKGIMEEDEACGRQYTLKKTTTYTQGVPPSQGDLEYQMSTTARAKRVREAMCPGVSGEDSSLLLATQVEGQATNLQRLAEPSQLLKSAIVHLINYQDDAELATRALPELTKLLNDEDPVVVTKAAMIVNQLSKKEASRRALMGSPQLVAAVVRTMQNTSDLDTARCTTSILHNLSHHREGLLAIFKSGGIPALVRMLSSPVESVLFYAITTLHNLLLYQEGAKMAVRLADGLQKMVPLLNKNNPKFLAITTDCLQLLAYGNQESKLIILANGGPQALVQIMRNYSYEKLLWTTSRVLKVLSVCPSNKPAIVEAGGMQALGKHLTSNSPRLVQNCLWTLRNLSDVATKQEGLESVLKILVNQLSVDDVNVLTCATGTLSNLTCNNSKNKTLVTQNSGVEALIHAILRAGDKDDITEPAVCALRHLTSRHPEAEMAQNSVRLNYGIPAIVKLLNQPNQWPLVKATIGLIRNLALCPANHAPLQEAAVIPRLVQLLVKAHQDAQRHVAAGTQQPYTDGVRMEEIVEGCTGALHILARDPMNRMEIFRLNTIPLFVQLLYSSVENIQRVAAGVLCELAQDKEAADAIDAEGASAPLMELLHSRNEGTATYAAAVLFRISEDKNPDYRKRVSVELTNSLFKHDPAAWEAAQSMIPINEPYGDDMDATYRPMYSSDVPLDPLEMHMDMDGDYPIDTYSDGLRPPYPTADHMLA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MEVMNLME -------CCCCCCCC | 8.70 | 22223895 | |
14 | Phosphorylation | MEQPIKVTEWQQTYT CCCCEEEEEEEEEEE | 26.89 | 21945579 | |
14 | O-linked_Glycosylation | MEQPIKVTEWQQTYT CCCCEEEEEEEEEEE | 26.89 | 28510447 | |
19 | Phosphorylation | KVTEWQQTYTYDSGI EEEEEEEEEECCCCC | 11.61 | 21945579 | |
20 | Phosphorylation | VTEWQQTYTYDSGIH EEEEEEEEECCCCCC | 10.04 | 21945579 | |
21 | Phosphorylation | TEWQQTYTYDSGIHS EEEEEEEECCCCCCC | 25.00 | 21945579 | |
22 | Phosphorylation | EWQQTYTYDSGIHSG EEEEEEECCCCCCCC | 9.56 | 21945579 | |
24 | Phosphorylation | QQTYTYDSGIHSGAN EEEEECCCCCCCCCC | 29.27 | 21945579 | |
28 | Phosphorylation | TYDSGIHSGANTCVP ECCCCCCCCCCCCCC | 37.37 | 21945579 | |
32 | Phosphorylation | GIHSGANTCVPSVSS CCCCCCCCCCCCCCC | 17.85 | 21945579 | |
36 | Phosphorylation | GANTCVPSVSSKGIM CCCCCCCCCCCCCCC | 17.77 | 21945579 | |
38 | Phosphorylation | NTCVPSVSSKGIMEE CCCCCCCCCCCCCCC | 30.58 | 21945579 | |
39 | Phosphorylation | TCVPSVSSKGIMEED CCCCCCCCCCCCCCH | 32.52 | 21945579 | |
40 | Ubiquitination | CVPSVSSKGIMEEDE CCCCCCCCCCCCCHH | 44.97 | 21906983 | |
53 | Phosphorylation | DEACGRQYTLKKTTT HHHCCCEEEEEEEEE | 16.81 | 21945579 | |
54 | Phosphorylation | EACGRQYTLKKTTTY HHCCCEEEEEEEEEE | 24.62 | 21945579 | |
56 | Ubiquitination | CGRQYTLKKTTTYTQ CCCEEEEEEEEEECC | 40.03 | - | |
57 | Ubiquitination | GRQYTLKKTTTYTQG CCEEEEEEEEEECCC | 54.97 | - | |
58 | Phosphorylation | RQYTLKKTTTYTQGV CEEEEEEEEEECCCC | 23.84 | 21945579 | |
59 | Phosphorylation | QYTLKKTTTYTQGVP EEEEEEEEEECCCCC | 27.04 | 21945579 | |
60 | Phosphorylation | YTLKKTTTYTQGVPP EEEEEEEEECCCCCC | 29.78 | 21945579 | |
61 | Phosphorylation | TLKKTTTYTQGVPPS EEEEEEEECCCCCCC | 8.58 | 21945579 | |
62 | Phosphorylation | LKKTTTYTQGVPPSQ EEEEEEECCCCCCCC | 19.43 | 21945579 | |
68 | Phosphorylation | YTQGVPPSQGDLEYQ ECCCCCCCCCCCHHH | 40.50 | 21945579 | |
74 | Phosphorylation | PSQGDLEYQMSTTAR CCCCCCHHHHHHHHH | 19.47 | 21945579 | |
77 | Phosphorylation | GDLEYQMSTTARAKR CCCHHHHHHHHHHHH | 13.69 | 21945579 | |
78 | Phosphorylation | DLEYQMSTTARAKRV CCHHHHHHHHHHHHH | 21.09 | 21945579 | |
79 | Phosphorylation | LEYQMSTTARAKRVR CHHHHHHHHHHHHHH | 13.57 | 21945579 | |
94 | Phosphorylation | EAMCPGVSGEDSSLL HHHCCCCCCCCCHHE | 42.24 | 28555341 | |
98 | Phosphorylation | PGVSGEDSSLLLATQ CCCCCCCCHHEEEEE | 20.70 | 26657352 | |
99 | Phosphorylation | GVSGEDSSLLLATQV CCCCCCCHHEEEEEE | 35.04 | 28857561 | |
104 | Phosphorylation | DSSLLLATQVEGQAT CCHHEEEEEEECCCC | 32.87 | 28857561 | |
120 | Phosphorylation | LQRLAEPSQLLKSAI HHHHHCHHHHHHHHH | 25.60 | 20068231 | |
124 | Ubiquitination | AEPSQLLKSAIVHLI HCHHHHHHHHHHHHH | 46.57 | 21906983 | |
125 | Phosphorylation | EPSQLLKSAIVHLIN CHHHHHHHHHHHHHC | 24.17 | 28152594 | |
133 | Phosphorylation | AIVHLINYQDDAELA HHHHHHCCCCHHHHH | 13.31 | 28152594 | |
141 | Phosphorylation | QDDAELATRALPELT CCHHHHHHHHHHHHH | 29.15 | 22817900 | |
149 | Ubiquitination | RALPELTKLLNDEDP HHHHHHHHHCCCCCC | 64.70 | 21906983 | |
160 | Phosphorylation | DEDPVVVTKAAMIVN CCCCHHHHHHHHHHH | 11.89 | - | |
161 | Ubiquitination | EDPVVVTKAAMIVNQ CCCHHHHHHHHHHHH | 23.65 | 21906983 | |
170 | Phosphorylation | AMIVNQLSKKEASRR HHHHHHHCHHHHHHH | 31.73 | 20860994 | |
171 | Ubiquitination | MIVNQLSKKEASRRA HHHHHHCHHHHHHHH | 64.32 | - | |
175 | Phosphorylation | QLSKKEASRRALMGS HHCHHHHHHHHHCCC | 24.32 | 29514088 | |
182 | Phosphorylation | SRRALMGSPQLVAAV HHHHHCCCHHHHHHH | 8.77 | 26846344 | |
193 | Sulfoxidation | VAAVVRTMQNTSDLD HHHHHHHHCCCCCCH | 1.71 | 28183972 | |
196 | Phosphorylation | VVRTMQNTSDLDTAR HHHHHCCCCCCHHHH | 13.51 | 28258704 | |
197 | Phosphorylation | VRTMQNTSDLDTARC HHHHCCCCCCHHHHH | 43.66 | 27251275 | |
201 | Phosphorylation | QNTSDLDTARCTTSI CCCCCCHHHHHHHHH | 24.25 | 28258704 | |
224 | Ubiquitination | EGLLAIFKSGGIPAL CCHHHHHHCCCHHHH | 41.92 | 21906983 | |
272 | Ubiquitination | RLADGLQKMVPLLNK HHHHHHHHHHHHHCC | 47.08 | - | |
279 | Ubiquitination | KMVPLLNKNNPKFLA HHHHHHCCCCCCEEE | 59.06 | - | |
322 | Phosphorylation | LVQIMRNYSYEKLLW HHHHHHHCCHHHHHH | 11.41 | 29978859 | |
323 | Phosphorylation | VQIMRNYSYEKLLWT HHHHHHCCHHHHHHH | 30.30 | 29978859 | |
324 | Phosphorylation | QIMRNYSYEKLLWTT HHHHHCCHHHHHHHH | 13.51 | 29978859 | |
326 | Ubiquitination | MRNYSYEKLLWTTSR HHHCCHHHHHHHHHH | 40.42 | - | |
326 | Acetylation | MRNYSYEKLLWTTSR HHHCCHHHHHHHHHH | 40.42 | 25825284 | |
336 | Acetylation | WTTSRVLKVLSVCPS HHHHHHHHHHHCCCC | 37.97 | 26051181 | |
336 | Ubiquitination | WTTSRVLKVLSVCPS HHHHHHHHHHHCCCC | 37.97 | - | |
345 | Ubiquitination | LSVCPSNKPAIVEAG HHCCCCCCCEEEEEC | 39.91 | - | |
359 | Ubiquitination | GGMQALGKHLTSNSP CHHHHHHHHHCCCCH | 35.97 | - | |
385 | Ubiquitination | NLSDVATKQEGLESV HHHHHCHHHHHHHHH | 36.29 | 21906983 | |
401 | Phosphorylation | KILVNQLSVDDVNVL HHHHHCCCCCCEEEE | 17.46 | 23090842 | |
409 | Phosphorylation | VDDVNVLTCATGTLS CCCEEEEEECCCCHH | 8.87 | 23090842 | |
412 | Phosphorylation | VNVLTCATGTLSNLT EEEEEECCCCHHCCE | 32.61 | 23090842 | |
414 | Phosphorylation | VLTCATGTLSNLTCN EEEECCCCHHCCEEC | 23.74 | 23090842 | |
424 | Ubiquitination | NLTCNNSKNKTLVTQ CCEECCCCCCEEEEC | 65.67 | - | |
426 | Ubiquitination | TCNNSKNKTLVTQNS EECCCCCCEEEECCH | 47.15 | - | |
427 | Phosphorylation | CNNSKNKTLVTQNSG ECCCCCCEEEECCHH | 35.54 | 25867546 | |
430 | Phosphorylation | SKNKTLVTQNSGVEA CCCCEEEECCHHHHH | 25.75 | 22817900 | |
433 | Phosphorylation | KTLVTQNSGVEALIH CEEEECCHHHHHHHH | 34.10 | 25867546 | |
448 | Acetylation | AILRAGDKDDITEPA HHHHCCCCCCCCHHH | 57.28 | 26051181 | |
448 | Ubiquitination | AILRAGDKDDITEPA HHHHCCCCCCCCHHH | 57.28 | - | |
452 | Phosphorylation | AGDKDDITEPAVCAL CCCCCCCCHHHHHHH | 42.80 | 22210691 | |
463 | Phosphorylation | VCALRHLTSRHPEAE HHHHHHHHHCCCHHH | 20.00 | 22817900 | |
475 | Phosphorylation | EAEMAQNSVRLNYGI HHHHHHHHHHHHCCH | 9.13 | 22210691 | |
480 | Phosphorylation | QNSVRLNYGIPAIVK HHHHHHHCCHHHHHH | 22.48 | 27273156 | |
499 | Ubiquitination | PNQWPLVKATIGLIR CCCCHHHHHHHHHHH | 47.71 | 21906983 | |
533 | Ubiquitination | RLVQLLVKAHQDAQR HHHHHHHHHCHHHHH | 39.87 | - | |
546 | Phosphorylation | QRHVAAGTQQPYTDG HHHHHCCCCCCCCCC | 21.21 | 21945579 | |
550 | Phosphorylation | AAGTQQPYTDGVRME HCCCCCCCCCCCCHH | 17.08 | 21945579 | |
551 | Phosphorylation | AGTQQPYTDGVRMEE CCCCCCCCCCCCHHH | 32.72 | 21945579 | |
564 | Phosphorylation | EEIVEGCTGALHILA HHHHCHHCCHHHHHH | 36.02 | 20068231 | |
595 | Phosphorylation | LFVQLLYSSVENIQR HHHHHHHHCHHHHHH | 28.07 | 24719451 | |
596 | Phosphorylation | FVQLLYSSVENIQRV HHHHHHHCHHHHHHH | 21.64 | 22817900 | |
641 | Phosphorylation | LHSRNEGTATYAAAV HHHCCCCHHHHHHHH | 15.06 | 21945579 | |
643 | Phosphorylation | SRNEGTATYAAAVLF HCCCCHHHHHHHHHH | 17.33 | 21945579 | |
644 | Phosphorylation | RNEGTATYAAAVLFR CCCCHHHHHHHHHHH | 7.56 | 21945579 | |
660 | Phosphorylation | SEDKNPDYRKRVSVE HCCCCCCHHHHHHHH | 21.20 | 25394399 | |
664 | Phosphorylation | NPDYRKRVSVELTNS CCCHHHHHHHHHHHH | 9.37 | 17081983 | |
665 | Phosphorylation | PDYRKRVSVELTNSL CCHHHHHHHHHHHHH | 17.57 | 22167270 | |
669 | Phosphorylation | KRVSVELTNSLFKHD HHHHHHHHHHHHHCC | 14.84 | 22167270 | |
671 | Phosphorylation | VSVELTNSLFKHDPA HHHHHHHHHHHCCHH | 29.92 | 23927012 | |
701 | Phosphorylation | GDDMDATYRPMYSSD CCCCCCCCCCCCCCC | 17.91 | 22817900 | |
724 | Phosphorylation | HMDMDGDYPIDTYSD CCCCCCCCCCCCCCC | 13.97 | 22817900 | |
728 | Phosphorylation | DGDYPIDTYSDGLRP CCCCCCCCCCCCCCC | 26.16 | 24275569 | |
729 | Phosphorylation | GDYPIDTYSDGLRPP CCCCCCCCCCCCCCC | 10.87 | 22817900 | |
730 | Phosphorylation | DYPIDTYSDGLRPPY CCCCCCCCCCCCCCC | 27.56 | 10902626 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PLAK_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PLAK_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NTAQ1_HUMAN | WDYHV1 | physical | 16189514 | |
RIBC2_HUMAN | RIBC2 | physical | 16189514 | |
IKBE_HUMAN | NFKBIE | physical | 16189514 | |
CNBP1_HUMAN | CTNNBIP1 | physical | 16189514 | |
CTNA1_HUMAN | CTNNA1 | physical | 9762469 | |
APC_HUMAN | APC | physical | 8074697 | |
CADH1_HUMAN | CDH1 | physical | 8074697 | |
ERBB2_HUMAN | ERBB2 | physical | 7702605 | |
DESP_HUMAN | DSP | physical | 9348293 | |
DSG2_HUMAN | DSG2 | physical | 10769205 | |
DSG2_HUMAN | DSG2 | physical | 8749329 | |
CTNA1_HUMAN | CTNNA1 | physical | 9110993 | |
CADH1_MOUSE | Cdh1 | physical | 12847106 | |
DSC1_MOUSE | Dsc1 | physical | 12847106 | |
DSG1A_MOUSE | Dsg1a | physical | 12847106 | |
DSC1_HUMAN | DSC1 | physical | 14673151 | |
PLEC_HUMAN | PLEC | physical | 22939629 | |
PTH2_HUMAN | PTRH2 | physical | 22939629 | |
RL21_HUMAN | RPL21 | physical | 22939629 | |
S2544_HUMAN | SLC25A44 | physical | 22939629 | |
SYIM_HUMAN | IARS2 | physical | 22939629 | |
CC130_HUMAN | CCDC130 | physical | 22365833 | |
CTNA3_HUMAN | CTNNA3 | physical | 23718855 | |
NFAC4_HUMAN | NFATC4 | physical | 21988832 | |
CTNA1_HUMAN | CTNNA1 | physical | 25241761 | |
APC_HUMAN | APC | physical | 25241761 | |
ERBB2_HUMAN | ERBB2 | physical | 25241761 | |
CTNB1_HUMAN | CTNNB1 | physical | 25241761 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00293 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | |||||
H00669 | Naxos disease and Carvajal syndrome | |||||
OMIM Disease | ||||||
601214 | Naxos disease (NXD) | |||||
611528 | Arrhythmogenic right ventricular dysplasia, familial, 12 (ARVD12) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-182 AND SER-665, ANDMASS SPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-660, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-660, AND MASSSPECTROMETRY. | |
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules."; Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.; Mol. Cell. Proteomics 4:1240-1250(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-20, AND MASSSPECTROMETRY. |